From the Editors

The November issue of The Oncology Nurse-APN/PA (TON) is full of important news and updates for oncology nurses.

Results from another clinical trial, ALEX, were also presented at the meeting, and led to alectinib (Alecensa), a next-generation anaplastic lymphoma kinase (ALK) inhibitor, being hailed as a new standard of care for patients with ALK mutation–positive non–small-cell lung cancer.

Here's what you can expect to find in the August issue of The Oncology Pharmacist.
Here is what you can expect to read in the July issue of The Oncology Nurse-APN/PA.
The May issue of The Oncology Nurse-APN/PA (TON) is full of important news and updates for oncology nurses
In the May issue of The Oncology Pharmacist (TOP), we feature a conversation with Patrick J. Medina, PharmD, BCOP, Professor of Clinical and Administrative Sciences at the University of Oklahoma College of Pharmacy in Tulsa, in which he discusses changes to the reimbursement model, bridging the knowledge gap in a rapidly evolving field, and why provider status is the “holy grail” of pharmacy.
What to expect in this month's issue of The Oncology Nurse APN/PA
Here's what to expect from the February issue of The Oncology Pharmacist.
The January issue of The Oncology Nurse-APN/PA (TON) is full of important news and updates for oncology nurses
Here's what you can expect to see in this month's issue of The Oncology Nurse APN/PA.
Page 1 of 6
Results 1 - 10 of 58